Prediction, prevention and management of postresection liver failure

British Journal of Surgery

Volumn 98, Issue 9, 2011, Pages 1188-1200

  Hammond, J S ^a   Guha, I N ^a   Beckingham, I J ^a   Lobo, D N ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

BLEEDING; FATTY LIVER; HUMAN; LIVER FAILURE; LIVER FUNCTION TEST; LIVER REGENERATION; LIVER RESECTION; LIVER TRANSPLANTATION; METHODOLOGY; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; REVIEW; RISK ASSESSMENT; RISK FACTOR;

ANTINEOPLASTIC AGENTS; BLOOD LOSS, SURGICAL; FATTY LIVER; HEPATECTOMY; HUMANS; LIVER FAILURE; LIVER FUNCTION TESTS; LIVER REGENERATION; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; RISK FACTORS;

EID: 79960826836     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7630     Document Type: Review

References (139)

1. Lock JF, Reinhold T, Malinowski M, Pratschke J, Neuhaus P, Stockmann M,. The costs of postoperative liver failure and the economic impact of liver function capacity after extended liver resection-a single-center experience. Langenbecks Arch Surg 2009; 394: 1047-1056.
2. Helling TS,. Liver failure following partial hepatectomy. HPB (Oxford) 2006; 8: 165-174. (Pubitemid 43832442)
3. van den Broek MA, Olde Damink SW, Dejong CH, Lang H, Malagõ M, Jalan R, et al., Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment. Liver Int 2008; 28: 767-780. (Pubitemid 351818638)
4. Garcea G, Maddern GJ,. Liver failure after major hepatic resection. J Hepatobiliary Pancreat Surg 2009; 16: 145-155.
5. Bosetti C, Levi F, Lucchini F, Zatonski W, Negri E, La Vecchia C,. Worldwide mortality from cirrhosis: an update to 2002. J Hepatol 2007; 46: 827-839. (Pubitemid 46529045)
6. Bellentani S, Scaglioni F, Marino M, Bedogni G,. Epidemiology of non-alcoholic fatty liver disease. Dig Dis 2010; 28: 155-161.
7. Chun YS, Laurent A, Maru D, Vauthey J-N,. Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases. Lancet Oncol 2009; 10: 278-286.
8. Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, et al., Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004; 240: 644-657.
9. Foster JH,. Survival after liver resection for secondary tumors. Am J Surg 1978; 135: 389-394. (Pubitemid 8298456)
10. Couinaud C,. Etudes Anatomiques et Chirurgicales. Masson: Paris, 1957.
11. Fortner J, Blumgart L,. A historic perspective of liver surgery at the end of the millenium. J Am Coll Surg 2001; 193: 210-222. (Pubitemid 32729624)
12. Redai I, Emond J, Brentjens T,. Anesthetic considerations during liver surgery. Surg Clin North Am 2004; 84: 401-411. (Pubitemid 38388274)
13. Swisher SG, Deford L, Merriman KW, Walsh GL, Smythe R, Vaporicyan A, et al., Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg 2000; 119: 1126-1132.
14. NHS Executive. Guidance on Commissioning Cancer Services: Improving Outcomes in Upper Gastro-intestinal Cancers. Department of Health: London, 2001; [accessed 1 February 2011].
15. House MG, Ito H, Gönen M, Fong Y, Allen PJ, DeMatteo RP, et al., Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1600 patients during two decades at a single institution. J Am Coll Surg 2010; 210: 744-752.
16. Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, et al., Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg 2004; 240: 698-708.
17. Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K, et al., One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 2003; 138: 1198-1206. (Pubitemid 37392393)
18. Virani S, Michaelson JS, Hutter MM, Lancaster RT, Warshaw AL, Henderson WG, et al., Morbidity and mortality after liver resection: results of the patient safety in surgery study. J Am Coll Surg 2007; 204: 1284-1292. (Pubitemid 46819089)
19. Rees M, Plant G, Bygrave S,. Late results justify resection for multiple hepatic metastases from colorectal cancer. Br J Surg 1997; 84: 1136-1140. (Pubitemid 27359495)
20. Midorikawa Y, Kubota K, Takayama T, Toyoda H, Ijichi M, Torzilli G, et al., A comparative study of postoperative complications after hepatectomy in patients with and without chronic liver disease. Surgery 1999; 126: 484-491. (Pubitemid 29421035)
21. Akashi K, Mizuno S, Isaji S,. Comparative study of perioperative management of hepatic resection. Dig Dis Sci 2000; 45: 1988-1995.
22. Cherqui D, Benoist S, Malassagne B, Humeres R, Rodriguez V, Fagniez PL,. Major liver resection for carcinoma in jaundiced patients without preoperative biliary drainage. Arch Surg 2000; 135: 302-308. (Pubitemid 30154571)
23. McCall J, Koea J, Gunn K, Rodgers M, Jarvis J,. Liver resections in Auckland 1998-2001: mortality, morbidity and blood product use. N Z Med J 2001; 114: 516-519. (Pubitemid 33101042)
24. Das BC, Isaji S, Kawarada Y,. Analysis of 100 consecutive hepatectomies: risk factors in patients with liver cirrhosis or obstructive jaundice. World J Surg 2001; 25: 266-272. (Pubitemid 32410361)
25. Sun HC, Qin LX, Wang L, Ye QH, Wu ZQ, Fan J, et al., Risk factors for postoperative complications after liver resection. Hepatobiliary Pancreat Dis Int 2005; 4: 370-374. (Pubitemid 41207536)
26. Schindl M, Redhead D, Fearon K, Garden O, Wigmore S,; Edinburgh Liver Surgery and Transplantation Experimental Research Group (eLISTER). The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 2005; 54: 289-296. (Pubitemid 40139248)
27. Mullen JT, Ribero D, Reddy SK, Donadon M, Zorzi D, Gautam S, et al., Hepatic insufficiency and mortality in 1059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 2007; 204: 854-862. (Pubitemid 46661186)
28. Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, et al., The '50-50 criteria' on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 2005; 242: 824-829. (Pubitemid 41714060)
29. de Meijer VE, Kalish BT, Puder M, Ijzermans JN,. Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection. Br J Surg 2010; 97: 1331-1339.
30. Strasberg SM,. Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg 2005; 12: 351-355. (Pubitemid 41662443)
31. Michalopoulos GK,. Liver regeneration. J Cell Physiol 2007; 213: 286-300. (Pubitemid 47509705)
32. Fausto N,. Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology 2004; 39: 1477-1487. (Pubitemid 38702646)
33. Clavien P-A, Oberkofler CE, Raptis DA, Lehmann K, Rickenbacher A, El-Badry AM,. What is critical for liver surgery and partial liver transplantation: size or quality? Hepatology 2010; 52: 715-729.
34. Demetris AJ, Kelly DM, Eghtesad B, Fontes P, Marsh JW, Tom K, et al., Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome. Am J Surg Pathol 2006; 30: 986-993. (Pubitemid 44264948)
35. Cornell R,. Gut-derived endotoxin elicits hepatotrophic factor secretion of liver regeneration. Am J Physiol 1985; 249: R551-R562. (Pubitemid 16204010)
36. Boermeester MA, Straatsburg IH, Houdijk AP, Meyer C, Frederiks WM, Wesdorp RI, et al., Endotoxin and interleukin-1 related hepatic inflammatory response promotes liver failure after partial hepatectomy. Hepatology 1995; 22: 1499-1506.
37. Panis Y, McMullan DM, Emond JC,. Progressive necrosis after hepatectomy and the pathophysiology of liver failure after massive resection. Surgery 1997; 121: 142-149. (Pubitemid 27091768)
38. Jaeschke H,. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003; 284: G15-G26. (Pubitemid 36076246)
39. Selzner N, Rudiger H, Graf R, Clavien P-A,. Protective strategies against ischemic injury of the liver. Gastroenterology 2003; 125: 917-936. (Pubitemid 37070708)
40. Clavien P-A, Petrowsky H, DeOliveira ML, Graf R,. Medical Progress: Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 2007; 356: 1545-1559. (Pubitemid 46588419)
41. Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, et al., Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 1997; 26: 1176-1181. (Pubitemid 27509300)
42. Shoup M, Gonen M, D'Angelica M, Jarnagin WR, DeMatteo R, Schwartz LH, et al., Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg 2003; 7: 325-330. (Pubitemid 36875770)
43. Dello SA, van Dam RM, Slangen JJ, van de Poll MC, Bemelmans MH, Greve JW, et al., Liver volumetry plug and play: do it yourself with ImageJ. World J Surg 2007; 31: 2215-2221. (Pubitemid 47620219)
44. Lamadé W, Glombitza G, Fischer L, Chiu P, Cárdenas CE, Thorn M, et al., The impact of 3-dimensional reconstructions on operation planning in liver surgery. Arch Surg 2000; 135: 1256-1261.
45. Vauthey J-N, Abdalla EK, Doherty DA, Gertsch P, Fenstermacher MJ, Loyer EM, et al., Body surface area and body weight predict total liver volume in Western adults. Liver Transplant 2002; 8: 233-240. (Pubitemid 34257205)
46. Brooks AJ, Hammond JS, Girling K, Beckingham IJ,. The effect of hepatic vascular inflow occlusion on liver tissue pH, carbon dioxide, and oxygen partial pressures: defining the optimal clamp/release regime for intermittent portal clamping. J Surg Res 2007; 141: 247-251. (Pubitemid 47042053)
47. Belghiti J, Noun R, Zante E, Ballet T, Sauvanet A,. Portal triad clamping or hepatic vascular exclusion for major liver resection. A controlled study. Ann Surg 1996; 224: 155-161. (Pubitemid 26272061)
48. Belghiti J, Noun R, Malafosse R, Jagot P, Sauvanet A, Pierangeli F, et al., Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann Surg 1999; 229: 369-375. (Pubitemid 30191772)
49. Kooby DA, Stockman J, Ben-Porat L, Gonen M, Jarnagin WR, Dematteo RP, et al., Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 2003; 237: 860-869.
50. Jensen LS, Andersen AJ, Christiansen PM, Hokland P, Juhl CO, Madsen G, et al., Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992; 79: 513-516.
51. Sihler KC, Napolitano LM,. Complications of massive transfusion. Chest 2010; 137: 209-220.
52. Sarmiento JM, Bower TC, Cherry KJ, Farnell MB, Nagorney DM,. Is combined partial hepatectomy with segmental resection of inferior vena cava justified for malignancy? Arch Surg 2003; 138: 624-630.
53. Azoulay D, Andreani P, Maggi U, Salloum C, Perdigao F, Sebagh M, et al., Combined liver resection and reconstruction of the supra-renal vena cava: the Paul Brousse experience. Ann Surg 2006; 244: 80-88. (Pubitemid 44297451)
54. Lodge JP, Ammori BJ, Prasad KR, Bellamy MC,. Ex vivo and in situ resection of inferior vena cava with hepatectomy for colorectal metastases. Ann Surg 2000; 231: 471-479. (Pubitemid 30185852)
55. Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, et al., Improvement in perioperative outcome after hepatic resection: analysis of 1803 consecutive cases over the past decade. Ann Surg 2002; 236: 397-406.
56. Poon RT, Fan ST,. Assessment of hepatic reserve for indication of hepatic resection: how I do it. J Hepatobiliary Pancreat Surg 2005; 12: 31-37. (Pubitemid 40378838)
57. Forner A, Reig ME, de Lope CR, Bruix J,. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis 2010; 30: 61-74.
58. Yeh MM, Brunt EM,. Pathology of nonalcoholic fatty liver disease. Am J Clin Pathol 2007; 128: 837-847. (Pubitemid 350133997)
59. Gomez D, Malik HZ, Bonney GK, Wong V, Toogood GJ, Lodge JP, et al., Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. Br J Surg 2007; 94: 1395-1402. (Pubitemid 350144389)
60. Nakano H, Oussoultzoglou E, Rosso E, Casnedi S, Chenard-Neu M-P, Dufour P, et al., Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 2008; 247: 118-124.
61. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, et al., Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006; 24: 2065-2072. (Pubitemid 46622116)
62. Karoui M, Penna C, Amin-Hashem M, Mitry E, Benoist S, Franc B, et al., Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006; 243: 1-7. (Pubitemid 43054046)
63. Aloysius MM, Zaitoun AM, Beckingham IJ, Neal KR, Aithal GP, Bessell E, et al., The pathological response to neoadjuvant chemotherapy with FOLFOX-4 for colorectal liver metastases: a comparative study. Virchows Arch 2007; 451: 943-948. (Pubitemid 350060742)
64. Mann DV, Lam WW, Hjelm NM, So NMC, Yeung DKW, Metreweli C, et al., Biliary drainage for obstructive jaundice enhances hepatic energy status in humans: a 31-phosphorus magnetic resonance spectroscopy study. Gut 2002; 50: 118-122. (Pubitemid 34028314)
65. Makino H, Shimizu H, Ito H, Kimura F, Ambiru S, Togawa A, et al., Changes in growth factor and cytokine expression in biliary obstructed rat liver and their relationship with delayed liver regeneration after partial hepatectomy. World J Gastroenterol 2006; 12: 2053-2059.
66. Sewnath ME, Karsten TM, Prins MH, Rauws EJ, Obertop H, Gouma DJ,. A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg 2002; 236: 17-27. (Pubitemid 34686446)
67. Laurent A, Tayar C, Cherqui D,. Cholangiocarcinoma: preoperative biliary drainage (Con). HPB (Oxford) 2008; 10: 126-129. (Pubitemid 351935000)
68. Nimura Y,. Preoperative biliary drainage before resection for cholangiocarcinoma (Pro). HPB (Oxford) 2008; 10: 130-133. (Pubitemid 351935001)
69. Iakova P, Awad SS, Timchenko NA,. Aging reduces proliferative capacities of liver by switching pathways of C/EBPalpha growth arrest. Cell 2003; 113: 495-506. (Pubitemid 36588752)
70. Bozzetti F,. Rationale and indications for preoperative feeding of malnourished surgical cancer patients. Nutrition 2002; 18: 953-959. (Pubitemid 35304806)
71. Fan ST, Lo CM, Lai E, Chu KM, Liu CL, Wong J,. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med 1994; 331: 1547-1552. (Pubitemid 24366901)
72. Awad S, Constantin-Teodosiu D, Macdonald IA, Lobo DN,. Short-term starvation and mitochondrial dysfunction-a possible mechanism leading to postoperative insulin resistance. Clin Nutr 2009; 28: 497-509.
73. Little SA, Jarnagin WR, DeMatteo RP, Blumgart LH, Fong Y,. Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer. J Gastrointest Surg 2002; 6: 88-94. (Pubitemid 40433594)
74. Yokoyama Y, Schwacha MG, Samy TS, Bland KI, Chaudry IH,. Gender dimorphism in immune responses following trauma and hemorrhage. Immunol Res 2002; 26: 63-76. (Pubitemid 35177485)
75. Zimmermann H, Reichen J,. Hepatectomy: preoperative analysis of hepatic function and postoperative liver failure. Dig Surg 1998; 15: 1-11. (Pubitemid 28048382)
76. Mullin EJ, Metcalfe MS, Maddern GJ,. How much liver resection is too much? Am J Surg 2005; 190: 87-97. (Pubitemid 40828612)
77. de Liguori Carino N, O'Reilly DA, Dajani K, Ghaneh P, Poston GJ, Wu AV,. Perioperative use of the LiMON method of indocyanine green elimination measurement for the prediction and early detection of post-hepatectomy liver failure. Eur J Surg Oncol 2009; 35: 957-962.
78. Fernandez FG, Ritter J, Goodwin JW, Linehan DC, Hawkins WG, Strasberg SM,. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 2005; 200: 845-853. (Pubitemid 40744790)
79. Guha IN, Parkes J, Roderick P, Chattopadhyay D, Cross R, Harris S, et al., Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European Liver Fibrosis Panel and exploring simple markers. Hepatology 2008; 47: 455-460. (Pubitemid 351280713)
80. O'Rourke TR, Welsh FK, Tekkis PP, Lyle N, Mustajab A, John TG, et al., Accuracy of liver-specific magnetic resonance imaging as a predictor of chemotherapy-associated hepatic cellular injury prior to liver resection. Eur J Surg Oncol 2009; 35: 1085-1091.
81. Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, et al., Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996; 111: 1018-1022. (Pubitemid 26327605)
82. Bosch J, Abraldes JG, Berzigotti A, García-Pagan JC,. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol 2009; 6: 573-582.
83. Awad S, Constantin-Teodosiu D, Constantin D, Rowlands BJ, Fearon KCH, Macdonald IA, et al., Cellular mechanisms underlying the protective effects of preoperative feeding: a randomized study investigating liver and muscle glycogen content, mitochondrial function, gene and protein expression. Ann Surg 2010; 252: 247-253.
84. Shirabe K, Matsumata T, Shimada M, Takenaka K, Kawahara N, Yamamoto K, et al., A comparison of parenteral hyperalimentation and early enteral feeding regarding systemic immunity after major hepatic resection-the results of a randomized prospective study. Hepatogastroenterology 1997; 44: 205-209. (Pubitemid 27096039)
85. Richter B, Schmandra TC, Golling M, Bechstein WO,. Nutritional support after open liver resection: a systematic review. Dig Surg 2006; 23: 139-145. (Pubitemid 44394163)
86. Bode LG, Kluytmans JA, Wertheim HF, Bogaers D, Vandenbroucke-Grauls CM, Roosendaal R, et al., Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010; 362: 9-17.
87. Madoff DC, Abdalla EK, Vauthey JN,. Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care. J Vasc Interv Radiol 2005; 16: 779-790. (Pubitemid 40847898)
88. Farges O, Belghiti J, Kianmanesh R, Regimbeau JM, Santoro R, Vilgrain V, et al., Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 2003; 237: 208-217. (Pubitemid 38173248)
89. Heinrich S, Jochum W, Graf R, Clavien PA,. Portal vein ligation and partial hepatectomy differentially influence growth of intrahepatic metastasis and liver regeneration in mice. J Hepatol 2006; 45: 35-42. (Pubitemid 43850620)
90. Pamecha V, Levene A, Grillo F, Woodward N, Dhillon A, Davidson BR,. Effect of portal vein embolisation on the growth rate of colorectal liver metastases. Br J Cancer 2009; 100: 617-622.
91. Selzner N, Pestalozzi BC, Kadry Z, Selzner M, Wildermuth S, Clavien PA,. Downstaging colorectal liver metastases by concomitant unilateral portal vein ligation and selective intra-arterial chemotherapy. Br J Surg 2006; 93: 587-592.
92. Jaeck D, Oussoultzoglou E, Rosso E, Greget M, Weber JC, Bachellier P,. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 2004; 240: 1037-1049.
93. Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, et al., Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239: 818-825.
94. Arkadopoulos N, Kostopanagiotou G, Theodoraki K, Farantos C, Theodosopoulos T, Stafyla V, et al., Ischemic preconditioning confers antiapoptotic protection during major hepatectomies performed under combined inflow and outflow exclusion of the liver. A randomized clinical trial. World J Surg 2009; 33: 1909-1915.
95. DuBay D, Gallinger S, Hawryluck L, Swallow C, McCluskey S, McGilvray I,. In situ hypothermic liver preservation during radical liver resection with major vascular reconstruction. Br J Surg 2009; 96: 1429-1436.
96. McKay A, Cassidy D, Sutherland F, Dixon E,. Clinical results of N-acetylcysteine after major hepatic surgery: a review. J Hepatobiliary Pancreat Surg 2008; 15: 473-478.
97. Luca A, Miraglia R, Caruso S, Milazzo M, Gidelli B, Bosch J,. Effects of splenic artery occlusion on portal pressure in patients with cirrhosis and portal hypertension. Liver Transplant 2006; 12: 1237-1243. (Pubitemid 44194592)
98. Boillot O, Delafosse B, Mechet I, Boucaud C, Pouyet M,. Small-for-size partial liver graft in an adult recipient; a new transplant technique. Lancet 2002; 359: 406-407. (Pubitemid 34158953)
99. Eipel C, Abshagen K, Ritter J, Cantré D, Menger MD, Vollmar B,. Splenectomy improves survival by increasing arterial blood supply in a rat model of reduced-size liver. Transpl Int 2010; 30: 986-993.
100. Bosch J, Abraldes JG, Fernández M, García-Pagán JC,. Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension. J Hepatol 2010; 53: 558-567.
101. Busani S, Marconi G, Schiavon L, Rinaldi L, Del Buono M, Masetti M, et al., Living donor liver transplantation and management of portal venous pressure. Transpl Proc 2006; 38: 1074-1075. (Pubitemid 43815921)
102. Lobo DN, Stanga Z, Aloysius MM, Wicks C, Nunes QM, Ingram KL, et al., Effect of volume loading with 1 liter intravenous infusions of 0·9% saline, 4% succinylated gelatine (Gelofusine) and 6% hydroxyethyl starch (Voluven) on blood volume and endocrine responses: a randomized, three-way crossover study in healthy volunteers. Crit Care Med 2010; 38: 464-470.
103. Rahman SH, Evans J, Toogood GJ, Lodge PA, Prasad KR,. Prognostic utility of postoperative C-reactive protein for posthepatectomy liver failure. Arch Surg 2008; 143: 247-253. (Pubitemid 351439273)
104. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al.,; Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32: 858-873. (Pubitemid 38344143)
105. Bernal W, Donaldson N, Wyncoll D, Wendon J,. Blood lactate as an early predictor of outcome in paracetamolinduced acute liver failure: a cohort study. Lancet 2002; 359: 558-563. (Pubitemid 34178437)
106. Bone RC,. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996; 24: 1125-1128.
107. Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R,. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000; 32: 734-739.
108. Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, et al., Circulating cytokines, chemokines, and stress hormones are increased in patients with organ dysfunction following liver resection. J Surg Res 2006; 133: 102-112.
109. de Liguori Carino N, O'Reilly DA, Dajani K, Ghaneh P, Poston GJ, Wu AV,. Perioperative use of the LiMON method of indocyanine green elimination measurement for the prediction and early detection of post-hepatectomy liver failure. Eur J Surg Oncol 2009; 35: 957-962.
110. Polson J, Lee WM,; American Association for the Study of Liver Disease. AASLD position paper: The management of acute liver failure. Hepatology 2005; 41: 1179-1197. (Pubitemid 40593928)
111. Jalan R,. Acute liver failure: current management and future prospects. J Hepatol 2005; 42: S115-S123. (Pubitemid 40364611)
112. Stravitz RT, Kramer DJ,; Medscape. Management of acute liver failure. Nat Rev Gastroenterol Hepatol 2009; 6: 542-553.
113. Varadhan KK, Lobo DN,. A meta-analysis of randomised controlled trials of intravenous fluid therapy in major elective open abdominal surgery: getting the balance right. Proc Nutr Soc 2010; 69: 488-498.
114. Rolando N, Gimson A, Wade J, Philpott-Howard J, Casewell M, Williams R,. Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant liver failure. Hepatology 1993; 17: 196-201. (Pubitemid 23046688)
115. Wu CC, Yeh DC, Lin MC, Liu TJ, P'Eng FK,. Prospective randomized trial of systemic antibiotics in patients undergoing liver resection. Br J Surg 1998; 85: 489-493.
116. Martin RC II, Jarnagin WR, Fong Y, Biernacki P, Blumgart LH, DeMatteo RP,. The use of fresh frozen plasma after major hepatic resection for colorectal metastasis: is there a standard for transfusion? J Am Coll Surg 2003; 196: 402-409. (Pubitemid 36343641)
117. O'Shaughnessy DF, Atterbury C, Maggs PB, Murphy M, Thomas D, Yates S, et al.,; British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004; 126: 11-28. (Pubitemid 38859478)
118. Schiødt FV, Balko J, Schilsky M, Harrison ME, Thornton A, Lee WM,; Acute Liver Failure Study Group. Thrombopoietin in acute liver failure. Hepatology 2003; 37: 558-561. (Pubitemid 36258777)
119. Drews RE, Weinberger SE,. Thrombocytopenic disorders in critically ill patients. Am J Respir Crit Care Med 2000; 162: 347-351. (Pubitemid 30647164)
120. Shami VM, Caldwell SH, Hespenheide EE, Arseneau KO, Bickston SJ, Macik BG,. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transpl 2003; 9: 138-143. (Pubitemid 36204564)
121. Lodge JP, Jonas S, Oussoultzoglou E, Malagõ M, Jayr C, Cherqui D, et al., Recombinant coagulation factor VIIa in major liver resection: a randomized, placebo-controlled, double-blind clinical trial. Anesthesiology 2005; 102: 269-275. (Pubitemid 40189073)
122. Cook D, Guyatt G, Marshall J, Leasa D, Fuller H, Hall R, et al., A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med 1998; 338: 791-797. (Pubitemid 28135985)
123. Levy MJ, Seelig CB, Robinson NJ, Ranney JE,. Comparison of omeprazole and ranitidine for stress ulcer prophylaxis. Dig Dis Sci 1997; 42: 1255-1259. (Pubitemid 27343453)
124. Cárdenas A, Ginès P, Runyon BA,. Is albumin infusion necessary after large volume paracentesis? Liver Int 2009; 29: 636-640.
125. Plauth M, Cabré E, Campillo B, Kondrup J, Marchesini G, Schutz T, et al., ESPEN guidelines on parenteral nutrition: hepatology. Clin Nutr 2009; 28: 436-444.
126. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al., Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345: 1359-1367.
127. DeLeve LD, Valla DC, Garcia-Tsao G,; American Association for the Study Liver Diseases. Vascular disorders of the liver. Hepatology 2009; 49: 1729-1764.
128. Arita J, Kokudo N, Hasegawa K, Sano K, Imamura H, Sugawara Y, et al., Hepatic venous thrombus formation during liver transection exposing major hepatic vein. Surgery 2007; 141: 283-284. (Pubitemid 46149879)
129. Adani GL, Baccarani U, Risaliti A, Sponza M, Gasparini D, Bresadola F, et al., Percutaneous transhepatic portography for the treatment of early portal vein thrombosis after surgery. Cardiovasc Interv Radiol 2007; 30: 1222-1226. (Pubitemid 350059813)
130. Jaffe V, Lygidakis NJ, Blumgart LH,. Acute portal vein thrombosis after right hepatic lobectomy: successful treatment by thrombectomy. Br J Surg 1982; 69: 211. (Pubitemid 12148882)
131. Ozeki Y, Umemoto T, Tateyama K, Katagiri Y, Katayama M, Sugiyama A,. Partial portal arterialization for dearterialized liver after hepatectomy. Br J Surg 1997; 84: 1011. (Pubitemid 27310881)
132. Fox I, Roy-Chowdhury J,. Hepatocyte transplantation. J Hepatol 2004; 40: 878-886. (Pubitemid 38670119)
133. Stutchfield BM, Forbes SJ, Wigmore SJ,. Prospects for stem cell transplantation in the treatment of hepatic disease. Liver Transpl 2010; 16: 827-836.
134. Otsuka Y, Duffy JP, Saab S, Farmer DG, Ghobrial RM, Hiatt JR, et al., Postresection hepatic failure: successful treatment with liver transplantation. Liver Transplant 2007; 13: 672-679. (Pubitemid 46796538)
135. Belghiti J, Durand F,. Hepatectomy vs. liver transplantation: a combination rather than an opposition. Liver Transplant 2007; 13: 636-638. (Pubitemid 46796529)
136. Stutchfield BM, Simpson K, Wigmore SJ,. Systematic review and meta-analysis of survival following extracorporeal liver support. Br J Surg 2011; 98: 623-631.
137. Dufour JF,. Vitamin E for nonalcoholic steatohepatitis: ready for prime time? Hepatology 2010; 52: 789-792.
138. Nakamuta M, Morizono S, Soejima Y, Yoshizumi T, Aishima S, Takasugi S, et al., Short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation. Transplantation 2005; 80: 608-612. (Pubitemid 41377747)
139. Hammond JS, Gilbert TW, Howard D, Zaitoun A, Michalopoulos G, Shakesheff KM, et al., Scaffolds containing growth factors and extracellular matrix induce hepatocyte proliferation and cell migration in normal and regenerating rat liver. J Hepatol 2011; 54: 279-287.